BLCM

Bellicum Pharmaceuticals, Inc.

Delisted

BLCM was delisted on the 1st of June, 2023.

28 hedge funds and large institutions have $2.13M invested in Bellicum Pharmaceuticals, Inc. in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
28
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$4.27K
2 +$1.37K
3 +$350
4
LPL Financial
LPL Financial
California
+$31

Top Sellers

1 -$90.2K
2 -$13K
3 -$9.36K
4
BFM
Boothbay Fund Management
New York
-$5.68K
5
UBS Group
UBS Group
Switzerland
-$3K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$537K
2
$437K
3
$393K
4
$299K
5
$92K
6
$87K
7
$68K
8
$54K
9
$36K
10
$33K
11
$16K
12
$16K
13
$13K
14
$13K
15
$12K
16
$10K
17
$7K
18
$2K
19
$1K
20
$1K
21
$1K
22
$12
23
24